These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11536265)

  • 1. Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophilias.
    Ochshorn Y; Kupferminc MJ; Eldor A; Wolman I; Lessing JB; Yaron Y
    Prenat Diagn; 2001 Aug; 21(8):658-61. PubMed ID: 11536265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption.
    Tikkanen M; Hämäläinen E; Nuutila M; Paavonen J; Ylikorkala O; Hiilesmaa V
    Prenat Diagn; 2007 Mar; 27(3):240-3. PubMed ID: 17238224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of inherited thrombophilias on first and second trimester maternal serum markers for aneuploidy.
    Derbent AU; Yanik FF; Inegöl Gümüş I; Simavli S; Turhan NÖ
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2177-81. PubMed ID: 22506595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of inherited thrombophilia on second trimester combined aneuploidy screening test markers.
    Cıkman MS; Seckin KD; Karslı MF; Baser E; Cıkman DI; Cicek MN
    Arch Gynecol Obstet; 2015 Apr; 291(4):787-90. PubMed ID: 25223861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between serum markers in the second trimester and placental pathology. A study on extremely small for gestational age fetuses.
    Morssink LP; de Wolf BT; Kornman LH; Beekhuis JR; van der Hall TP; Mantingh A
    Br J Obstet Gynaecol; 1996 Aug; 103(8):779-83. PubMed ID: 8760707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
    Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI
    Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between unexplained elevated maternal serum alpha fetoprotein and/or human chorionic gonadotropin and the occurrence of placental thrombotic lesions.
    Salim R; Okopnik M; Garmi G; Nachum Z; Zafran N; Shalev E
    Placenta; 2010 Apr; 31(4):277-81. PubMed ID: 20132984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between maternal serum alpha-fetoprotein and maternal haemoglobin.
    Bartha JL; Omar KM; Soothill PW
    Prenat Diagn; 2004 Aug; 24(8):609-12. PubMed ID: 15305347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery.
    Morssink LP; Kornman LH; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1995 Nov; 15(11):1041-6. PubMed ID: 8606883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of hereditary versus acquired thrombophilia on triple test Down's syndrome screening.
    Frank M; Maymon R; Wiener Y; Neeman O; Kurzweil Y; Bar J
    Prenat Diagn; 2013 Feb; 33(2):191-5. PubMed ID: 23292892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of combined serum biomarkers for adverse pregnancy outcomes.
    Cohen JL; Smilen KE; Bianco AT; Moshier EL; Ferrara LA; Stone JL
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():89-94. PubMed ID: 25129153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does low molecular weight heparin influence the triple test result in pregnant women with thrombophilia?
    Wiener Y; Frank M; Neeman O; Kurzweil Y; Bar J; Maymon R
    Isr Med Assoc J; 2012 Apr; 14(4):247-50. PubMed ID: 22675844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
    Pretorius DH; Budorick NE; Scioscia AL; Krabbe JK; Ko S; Myhre CM
    AJR Am J Roentgenol; 1993 Nov; 161(5):1007-13. PubMed ID: 7506005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
    Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
    Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between second-trimester maternal serum alpha-fetoprotein in 14-22 weeks and adverse pregnancy outcome.
    Dehghani-Firouzabadi R; Tayebi N; Ghasemi N; Tahmasbi Z
    Acta Med Iran; 2010; 48(4):234-8. PubMed ID: 21279936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies.
    Lepage N; Chitayat D; Kingdom J; Huang T
    Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes.
    Chandra S; Scott H; Dodds L; Watts C; Blight C; Van Den Hof M
    Am J Obstet Gynecol; 2003 Sep; 189(3):775-81. PubMed ID: 14526312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies.
    Bernstein IM; Barth RA; Miller R; Capeless EL
    Obstet Gynecol; 1992 Jan; 79(1):71-4. PubMed ID: 1370124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.